Essex Financial Services, Inc. Merck & Co., Inc. Transaction History

Essex Financial Services, Inc.

$2.07 Billion
Q3 2024

A detailed history of Essex Financial Services, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Essex Financial Services, Inc. holds 38,817 shares of MRK stock, worth $3.85 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

38,817

Previous 46,741 16.95%

Holding current value

$3.85 Million

Previous $5.79 Million 23.82%

% of portfolio

0.21%

Previous 0.28%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$111.15 - $128.97 $880,752 - $1.02 Million	-7,924 Reduced 16.95%	38,817 $4.41 Million
Q2 2024 Aug 09, 2024	BUY	$123.8 - $132.96 $160,816 - $172,715	1,299 Added 2.86%	46,741 $5.79 Million
Q2 2024 Jul 31, 2024	BUY	$123.8 - $132.96 $911,787 - $979,250	7,365 Added 19.34%	45,442 $5.63 Million
Q1 2024 Apr 23, 2024	BUY	$113.24 - $131.95 $142,682 - $166,257	1,260 Added 3.42%	38,077 $5.02 Million
Q4 2023 Feb 05, 2024	BUY	$100.18 - $109.02 $21,839 - $23,766	218 Added 0.6%	36,817 $4.01 Million
Q3 2023 Nov 15, 2023	SELL	$102.95 - $114.33 $70,006 - $77,744	-680 Reduced 1.82%	36,599 $3.77 Million
Q2 2023 Aug 08, 2023	SELL	$108.61 - $118.38 $130,766 - $142,529	-1,204 Reduced 3.13%	37,279 $4.3 Million
Q1 2023 May 11, 2023	SELL	$102.94 - $114.86 $51,984 - $58,004	-505 Reduced 1.3%	38,483 $4.09 Million
Q4 2022 Feb 10, 2023	BUY	$87.44 - $112.11 $78,433 - $100,562	897 Added 2.35%	38,988 $4.32 Million
Q3 2022 Nov 07, 2022	BUY	$84.53 - $94.96 $114,622 - $128,765	1,356 Added 3.69%	38,091 $3.28 Million
Q2 2022 Aug 01, 2022	BUY	$83.49 - $94.64 $67,459 - $76,469	808 Added 2.25%	36,735 $3.35 Million
Q1 2022 Apr 21, 2022	SELL	$73.51 - $82.4 $259,490 - $290,872	-3,530 Reduced 8.95%	35,927 $2.95 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $21,973 - $27,524	304 Added 0.78%	39,457 $3.02 Million
Q3 2021 Nov 10, 2021	BUY	$71.68 - $78.83 $693,073 - $762,207	9,669 Added 32.79%	39,153 $2.94 Million
Q1 2021 May 11, 2021	SELL	$68.86 - $81.11 $68,446 - $80,623	-994 Reduced 3.26%	29,484 $2.27 Million
Q4 2020 Feb 05, 2021	SELL	$71.77 - $79.65 $107,080 - $118,837	-1,492 Reduced 4.67%	30,478 $2.49 Million
Q3 2020 Nov 10, 2020	BUY	$73.18 - $82.95 $326,236 - $369,791	4,458 Added 16.2%	31,970 $2.65 Million
Q2 2020 Aug 06, 2020	SELL	$70.42 - $80.13 $188,373 - $214,347	-2,675 Reduced 8.86%	27,512 $2.13 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $102,136 - $141,565	-1,612 Reduced 5.07%	30,187 $2.32 Million
Q4 2019 Jan 30, 2020	BUY	$77.58 - $87.54 $351,127 - $396,206	4,526 Added 16.6%	31,799 $2.89 Million
Q3 2019 Nov 04, 2019	SELL	$76.08 - $82.93 $97,154 - $105,901	-1,277 Reduced 4.47%	27,273 $2.3 Million
Q2 2019 Jul 30, 2019	SELL	$69.84 - $81.59 $127,248 - $148,656	-1,822 Reduced 6.0%	28,550 $2.39 Million
Q1 2019 May 02, 2019	BUY	$69.58 - $79.36 $31,798 - $36,267	457 Added 1.53%	30,372 $2.53 Million
Q4 2018 Feb 07, 2019	SELL	$65.24 - $75.71 $298,277 - $346,146	-4,572 Reduced 13.26%	29,915 $2.29 Million
Q3 2018 Nov 05, 2018	SELL	$57.69 - $67.84 $18,287 - $21,505	-317 Reduced 0.91%	34,487 $2.45 Million
Q2 2018 Aug 07, 2018	BUY	$50.83 - $59.72 $153,354 - $180,175	3,017 Added 9.49%	34,804 $2.11 Million
Q1 2018 May 03, 2018	SELL	$50.96 - $59.23 $439,428 - $510,740	-8,623 Reduced 21.34%	31,787 $1.73 Million
Q4 2017 Feb 07, 2018	SELL	$51.62 - $61.64 $160,589 - $191,762	-3,111 Reduced 7.15%	40,410 $2.27 Million
Q3 2017 Nov 03, 2017	SELL	$58.67 - $63.13 $46,525 - $50,062	-793 Reduced 1.79%	43,521 $2.79 Million
Q2 2017 Aug 07, 2017	BUY	N/A	44,314	44,314 $2.84 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Essex Financial Services, Inc. with notifications on news.

Account

Essex Financial Services, Inc. Merck & Co., Inc. Transaction History